A method for preparing
lignan-derived schisandrol A, belonging to the field of
medicinal chemistry. The method comprises: 1. Preparing intermediate 1 using 3,4,5-trimethoxybenzaldehyde and N-
bromosuccinimide; 2. Preparing intermediate 2 using intermediate 1, a
nickel catalyst, a ligand,
tetrabutylammonium iodide, and
zinc powder; 3. Preparing intermediate 3 using intermediate 2, methyl chloropropionate, and an
organic base; 4. Preparing intermediate 4 using intermediate 3, ethyltriphenylphosphine
bromide, and
potassium tert-butoxide; 5. Preparing intermediate 5 using intermediate 4, an alkaline solution, and
hydrochloric acid; 6. Preparing
lignan-derived schisandrol A using intermediate 5, a
samarium catalyst,
hexamethylphosphoramide, and tert-
butanol. This invention optimizes the reaction pathway, requiring only 6 steps to efficiently synthesize schisandrol A, significantly shortening the traditional synthetic
route, improving overall reaction efficiency and the total yield of the target product. Tests show that schisandrol A has good
antibacterial activity against *
Escherichia coli* and *
Staphylococcus aureus*.